IDIBELL on the media
IDIBELL researchers analyze the evidence of iron supplementation in chronic heart failure
They have shown that intravenous iron administration improves the quality of life and prognosis in patients with heart failure and ventricular dysfunction.
The IDIBELL-Ins Bellvitge Tandem opens the academic year with the inauguration of new scientific instruments for the secondary school laboratory
During the academic year that is beginning, the Tandem will continue educational projects that have been successful in recent years, such as the production of Life & Science magazine, the European Stars Game project, the Women of Science series, or the implementation of new laboratory practices in charge of the URIB
Access to quality medical and emotional information during breast cancer through digital platforms could reduce patient discomfort
Misinformation about the disease is one of the most stressful factors for patients. For this reason, creating quality content could help maintain emotional well-being.
A study with IDIBELL participation validates the effectiveness of biological treatments in severe asthma cases
The multicenter study in real life at the state level has been carried out with patients with severe asthma from a dozen hospitals and its main conclusion is that biological therapy is effective in both cases
The age at onset of multiple sclerosis has increased over the last decades
An IDIBELL and the Bellvitge University Hospital study has detected that the age at which the first symptoms appear has progressively increased from 1970 to 2019.
An IDIBELL study identifies the mechanisms by which NOX4 acts as a molecular brake on liver cancer
The work shows that in a NOX4 low activity situation, liver cancer cells reprogram the metabolism, causing oxidative stress, which favors tumor progression.
A clinical trial with IDIBELL participation confirms the benefits of a new drug in heart failure
Dapagliflozin significantly reduces the risk of cardiovascular death and hospitalizations for heart failure (HF).
A new endometrial cancer screening test that can be done at home
It is an epigenetic test capable of detecting between 90 and 100% of cases of endometrial cancer. This new rapid and non-invasive method can be performed: on cervical cytology samples obtained in the doctor’s office, and on vaginal self-samples collected at home.
Early physical therapy in patients with severe COVID-19 can reduce hospitalization days
A retrospective study by IDIBELL and the Bellvitge University Hospital shows that starting physical rehabilitation of patients admitted to the UCRI with severe COVID-19 before seven days reduces hospitalization time.
An incidental finding in prostate biopsies allows the diagnosis of a previously unsuspected systemic disease
The research, led by researchers from IDIBELL and the Bellvitge University Hospital (HUB), has established that when amyloidosis is detected in the prostate, it is almost always the TTR-type systemic variant of the disease associated with aging.